Genentech, a member of Roche (RHHBY), announced topline results from the overall survival analysis of the Phase III INAVO120 study ...

Sarepta (SRPT) announced topline results from Part 2 of EMBARK, a global, randomized, double-blind, placebo-controlled, Phase 3 clinical study ...

Storm Eowyn has unleashed strong and damaging winds over the British Isles, and particularly over Ireland and Scotland.

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...